Park CS - Search Results

1

Prognostic significance of serum β2-microglobulin levels in patients with peripheral T-cell lymphoma not otherwise specified.

Kim HD, Cho H, Sohn BS, Park CS, Huh J, Ryu JS, Lee SW, Yoon SE, Kim SJ, Ko YH, Kim WS, Suh C. Kim HD, et al. Among authors: park cs. Leuk Lymphoma. 2022 Jan;63(1):124-130. doi: 10.1080/10428194.2021.1971220. Epub 2021 Oct 26. Leuk Lymphoma. 2022. PMID: 34702115

2

Expression of JL1 is an effective adjunctive marker of leukemia cutis.

Park YS, Park SH, Park SJ, Kim Y, Jang KT, Ko YH, Lee MW, Huh JR, Park CS. Park YS, et al. Among authors: park cs, park sj, park sh. Arch Pathol Lab Med. 2010 Jan;134(1):95-102. doi: 10.5858/2008-0699-OAR.1. Arch Pathol Lab Med. 2010. PMID: 20073611 Free article.

3

Expression of JL1 in Burkitt lymphoma is associated with improved overall survival.

Hwang I, Go H, Jeon YK, Ko YH, Yoon DH, Suh C, Huh JR, Lee H, Gil M, Park CS. Hwang I, et al. Among authors: park cs. Virchows Arch. 2011 Oct;459(4):353-9. doi: 10.1007/s00428-011-1134-6. Epub 2011 Aug 4. Virchows Arch. 2011. PMID: 21814778

4

CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma.

Yoon DH, Koh YW, Kang HJ, Kim S, Park CS, Lee SW, Suh C, Huh J. Yoon DH, et al. Among authors: park cs. Eur J Haematol. 2012 Apr;88(4):292-305. doi: 10.1111/j.1600-0609.2011.01731.x. Epub 2011 Nov 24. Eur J Haematol. 2012. PMID: 22044760

5

A phase I/II study of bortezomib plus CHOP every 2 weeks (CHOP-14) in patients with advanced-stage diffuse large B-cell lymphomas.

Kim JE, Yoon DH, Jang G, Lee DH, Kim S, Park CS, Huh J, Kim WS, Park J, Lee JH, Lee SI, Suh C. Kim JE, et al. Among authors: park cs, park j. Korean J Hematol. 2012 Mar;47(1):53-9. doi: 10.5045/kjh.2012.47.1.53. Epub 2012 Mar 28. Korean J Hematol. 2012. PMID: 22479278 Free PMC article.

6

Relapse pattern and prognostic factors for patients with primary central nervous system lymphoma.

Kim JE, Yoon DH, Kim S, Lee DH, Kim JH, Yoon YH, Chi HS, Lee SW, Park CS, Huh J, Suh C. Kim JE, et al. Among authors: park cs. Korean J Hematol. 2012 Mar;47(1):60-6. doi: 10.5045/kjh.2012.47.1.60. Epub 2012 Mar 28. Korean J Hematol. 2012. PMID: 22479279 Free PMC article.

7

Increment of hematopoietic progenitor cell count as an indicator of efficient autologs stem cell harvest in patients with multiple myeloma.

Jo JC, Yoon DH, Kim S, Jang S, Park CJ, Chi HS, Park CS, Huh J, Lee SW, Suh C. Jo JC, et al. Among authors: park cs, park cj. J Clin Apher. 2012 Nov;27(5):229-34. doi: 10.1002/jca.21231. Epub 2012 Apr 25. J Clin Apher. 2012. PMID: 22535685

8

Clinical features and prognostic model for extranasal NK/T-cell lymphoma.

Jo JC, Yoon DH, Kim S, Lee BJ, Jang YJ, Park CS, Huh J, Lee SW, Ryu JS, Suh C. Jo JC, et al. Among authors: park cs. Eur J Haematol. 2012 Aug;89(2):103-10. doi: 10.1111/j.1600-0609.2012.01796.x. Eur J Haematol. 2012. PMID: 22553935

9

The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages.

Koh YW, Kang HJ, Park C, Yoon DH, Kim S, Suh C, Go H, Kim JE, Kim CW, Huh J. Koh YW, et al. Oncologist. 2012;17(6):871-80. doi: 10.1634/theoncologist.2012-0034. Epub 2012 May 15. Oncologist. 2012. PMID: 22588324 Free PMC article.

10

Yttrium-90 ibritumomab tiuxetan plus busulfan, cyclophosphamide, and etoposide (BuCyE) versus BuCyE alone as a conditioning regimen for non-Hodgkin lymphoma.

Jo JC, Yoon DH, Kim S, Park JS, Park CS, Huh J, Lee SW, Ryu JS, Suh C. Jo JC, et al. Among authors: park cs, park js. Korean J Hematol. 2012 Jun;47(2):119-25. doi: 10.5045/kjh.2012.47.2.119. Epub 2012 Jun 26. Korean J Hematol. 2012. PMID: 22783358 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,820 results

Search Page